Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Entrada Therapeutics (TRDA) Tax Rate (2023 - 2025)

Entrada Therapeutics (TRDA) has 3 years of Tax Rate data on record, last reported at 0.32% in Q4 2025.

  • For Q4 2025, Tax Rate fell 25294.0% year-over-year to 0.32%; the TTM value through Dec 2025 reached 0.65%, down 200.0%, while the annual FY2025 figure was 0.65%, 200.0% down from the prior year.
  • Tax Rate reached 0.32% in Q4 2025 per TRDA's latest filing, up from 1.38% in the prior quarter.
  • Across five years, Tax Rate topped out at 252.62% in Q4 2024 and bottomed at 114.23% in Q2 2023.
  • Average Tax Rate over 3 years is 14.0%, with a median of 0.32% recorded in 2025.
  • Peak YoY movement for Tax Rate: surged 12081bps in 2024, then plummeted -25294bps in 2025.
  • A 3-year view of Tax Rate shows it stood at 203.77% in 2023, then grew by 24bps to 252.62% in 2024, then tumbled by -100bps to 0.32% in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Rate were 0.32% in Q4 2025, 1.38% in Q3 2025, and 0.47% in Q2 2025.